Gemcitabine is the hydrochloride salt of an analogue of the antimetabolite nucleoside deoxycytidine with antineoplastic activity. Gemcitabine HCl is a clinically useful anticancer agent. It exerts its cytotoxic effects via the metabolites gemcitabine diphosphate (dFdCDP) and gemcitabine triphosphate (dFdCTP). dFdCTP is an inhibitor of DNA polymerase and is also incorporated in DNA strands resulting in termination of chain elongation and apoptosis. dFdCDP is an inhibitor of ribonucleotide reductase which results in depletion of deoxyribonucleotides needed for DNA synthesis. Gemcitabine metabolites have also been reported to inhibit cytidine triphosphate synthetase (CTP synthetase) and deoxycytidylate deaminase (dCMP deaminase).
This report provides detailed analysis of worldwide markets for Gemcitabine Hydrochloride from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Gemcitabine Hydrochloride market and further lays out an analysis of the factors influencing the supply/demand for Gemcitabine Hydrochloride, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.
GCC’s report, Global Gemcitabine Hydrochloride Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Gemcitabine Hydrochloride market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Gemcitabine Hydrochloride market are ChemWerth (USA), Shilpa Medicare (India), FRESENIUS KABI (India), MSN Laboratories (India), ScinoPharm Taiwan (Taiwan), Shanghai Acebright (China), Fuan Pharmaceutical (China), JARI Pharmaceutical (China), Chiatai Qingjiang (China), Luoxin Group (China), among others.
The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Gemcitabine Hydrochloride industry has been provided.
Table Of Contents
Part 1. Scope of Report
1.1 Methodology
1.2 Geographic Scope
1.3 Years Considered
Part 2. Introduction
2.1 Definition
2.2 Current Scenario
2.2 Future Scenario
Part.3 Value Chain Analysis
3.1 Upstream
3.2 Downstream
Part 4. Manufacture
4.1 Manufacturing Process
4.2 Issues and Trends
4.3 Manufacturing Costs
Part 5. Worldwide Key Vendors
5.1 Company A
5.1.1 Business Overview
5.1.2 Products Offered
5.1.3 Business Performance
5.2 Company B
5.3 Company C
5.4 Company D
5.5 Company E
5.6 Company F
5.7 Company G
5.8 Company H
5.9 Company I
5.10 Company J
Part 6. Market Overview
6.1 Global Production Volume 2011-2016
6.2 Production Volume by Region 2011-2016
6.2.1 North America
6.2.2 EMEA
6.2.3 Asia-Pacific
6.2.4 ROW
6.3 Global Production Value 2011-2016
6.4 Production Value by Region
6.4.1 North America
6.4.2 EMEA
6.4.3 Asia-Pacific
6.4.4 ROW
Part 7. Consumption Pattern
7.1 Regional Consumption
7.1.1 North America
7.1.2 EMEA
7.1.3 Asia-Pacific
7.1.4 ROW
7.2 Global Consumption by Application
Part 8. Market Forecast
8.1 Market Size by Volume
8.1.1 North America
8.1.2 EMEA
8.1.3 Asia-Pacific
8.1.4 ROW
8.2 Market Size by Value
8.2.1 North America
8.2.2 EMEA
8.2.3 Asia-Pacific
8.2.4 ROW
8.3 Regional Consumption Forecast
8.3.1 North America
8.3.2 EMEA
8.3.3 Asia-Pacific
8.3.4 ROW
8.4 Consumption Forecast by Application
Part 9. Market Dynamics
9.1 Market Drivers
9.2 Market Constraints
9.3 Market Strategies
Part 10 Key Events
10.1 Mergers & Acquisitions
10.2 New Product Launches
10.3 Expansions
10.4 Other Developments
List Of Tables
Figure Global Gemcitabine Hydrochloride Production Volume (Unit) 2011-2016
Figure Global Gemcitabine Hydrochloride Production Value (M USD) 2011-2016
Figure Top 10 Gemcitabine Hydrochloride Vendors Production Volume Share 2015
Figure Top 10 Gemcitabine Hydrochloride Vendors Production Value Share 2015
Figure Regional Gemcitabine Hydrochloride Production (Unit) 2015
Figure Regional Gemcitabine Hydrochloride Production Value (M USD) 2015
Table Raw Material Materials Suppliers
Figure Global Gemcitabine Hydrochloride Consumption Pattern 2015
Figure Manufacturing Cost Structure
Figure Company A Gemcitabine Hydrochloride Products
Table Company A Financial Performance 2011-2016
Figure Company A Market Share 2011-2016
Figure Company B Gemcitabine Hydrochloride Products
Table Company B Financial Performance 2011-2016
Figure Company B Market Share 2011-2016
Figure Company C Gemcitabine Hydrochloride Products
Table Company C Financial Performance 2011-2016
Figure Company C Market Share 2011-2016
Figure Company D Gemcitabine Hydrochloride Products
Table Company D Financial Performance 2011-2016
Figure Company D Market Share 2011-2016
Figure Company E Gemcitabine Hydrochloride Products
Table Company E Financial Performance 2011-2016
Figure Company E Market Share 2011-2016
Figure Company F Gemcitabine Hydrochloride Products
Table Company F Financial Performance 2011-2016
Figure Company F Market Share 2011-2016
Figure Company G Gemcitabine Hydrochloride Products
Table Company G Financial Performance 2011-2016
Figure Company G Market Share 2011-2016
Figure Company H Gemcitabine Hydrochloride Products
Table Company H Financial Performance 2011-2016
Figure Company H Market Share 2011-2016
Figure Company I Gemcitabine Hydrochloride Products
Table Company I Financial Performance 2011-2016
Figure Company I Market Share 2011-2016
Figure Company J Gemcitabine Hydrochloride Products
Table Company J Financial Performance 2011-2016
Figure Company J Market Share 2011-2016
Table Global Key Gemcitabine Hydrochloride Vendors Production (Unit) 2011-2016
Table Global Key Gemcitabine Hydrochloride Vendors Production Share 2011-2016
Figure Global Gemcitabine Hydrochloride Capacity & Production (Unit), Capacity Utilization 2011-2016
Figure Global Top 10 Gemcitabine Hydrochloride Vendors Production (Unit) 2011-2016
Table Global Top 10 Gemcitabine Hydrochloride Vendors Production (Unit) 2011
Table Global Top 10 Gemcitabine Hydrochloride Vendors Production (Unit) 2012
Table Global Top 10 Gemcitabine Hydrochloride Vendors Production (Unit) 2013
Table Global Top 10 Gemcitabine Hydrochloride Vendors Production (Unit) 2014
Table Global Top 10 Gemcitabine Hydrochloride Vendors Production (Unit) 2015
Table Global Top 10 Gemcitabine Hydrochloride Vendors Production (Unit) 2016
Figure Gemcitabine Hydrochloride Production Volume (Unit) 2011-2016
Table Global Production Volume (Unit) 2011-2016
Table Global Production Volume Share 2011-2016
Figure North America Gemcitabine Hydrochloride Capacity & Production (Unit)
Figure North America Production Share Trend
Figure EMEA Gemcitabine Hydrochloride Capacity & Production (Unit)
Figure EMEA Production Share Trend
Figure Asia-Pacific Gemcitabine Hydrochloride Capacity & Production (Unit)
Figure Asia-Pacific Production Share Trend
Figure ROW Gemcitabine Hydrochloride Capacity & Production (Unit)
Figure ROW Production Share Trend Change
Figure Global Gemcitabine Hydrochloride Production Value (M USD), Growth Rate
Table Global Key Gemcitabine Hydrochloride Vendors Production Value (M USD) 2011-2016
Table Global Key Gemcitabine Hydrochloride Vendors Production Value Share 2011-2016
Figure Global Top 10 Gemcitabine Hydrochloride Vendors Production Value (M USD) 2011-2016
Table Global Top 10 Gemcitabine Hydrochloride Vendors Production Value (M USD) 2011
Table Global Top 10 Gemcitabine Hydrochloride Vendors Production Value (M USD) 2012
Table Global Top 10 Gemcitabine Hydrochloride Vendors Production Value (M USD) 2013
Table Global Top 10 Gemcitabine Hydrochloride Vendors Production Value (M USD) 2014
Table Global Top 10 Gemcitabine Hydrochloride Vendors Production Value (M USD) 2015
Table Global Top 10 Gemcitabine Hydrochloride Vendors Production Value (M USD) 2016
Figure Gemcitabine Hydrochloride Prices (USD/Ton) 2016
Figure Gemcitabine Hydrochloride Gross Margin 2016
Figure Gemcitabine Hydrochloride Production Value (M USD) By Region 2011-2016
Table Global Gemcitabine Hydrochloride Production Value (M USD) 2011-2016
Table Global Gemcitabine Hydrochloride Production Value Share 2011-2016
Figure North America Production Value (M USD), Growth Rate
Figure North America Gemcitabine Hydrochloride Production Value Share Trend
Figure EMEA Production Value (M USD), Growth Rate
Figure EMEA Gemcitabine Hydrochloride Production Value Share Trend
Figure Asia-Pacific Production Value (M USD), Growth Rate
Figure Asia-Pacific Gemcitabine Hydrochloride Production Value Share Trend
Figure ROW Production Value (M USD), Growth Rate
Figure ROW Gemcitabine Hydrochloride Production Value Share Trend
Figure Global Gemcitabine Hydrochloride Consumption Volume (Unit) 2015
Table Regional Gemcitabine Hydrochloride Consumption Volume (Unit) 2011-2016
Table Regional Gemcitabine Hydrochloride Consumption Volume Share 2011-2016
Figure Gemcitabine Hydrochloride Consumption in North America 2011-2016
Figure Gemcitabine Hydrochloride Consumption in EMEA 2011-2016
Figure Gemcitabine Hydrochloride Consumption in Asia-Pacific 2011-2016
Figure Gemcitabine Hydrochloride Consumption in ROW 2011-2016
Figure Global Gemcitabine Hydrochloride Consumption Volume (Unit) 2016
Table Global Gemcitabine Hydrochloride Consumption Volume (Unit) 2011-2016
Table Global Gemcitabine Hydrochloride Consumption Volume Share 2011-2016
Figure Global Gemcitabine Hydrochloride Production (Unit) Forecast 2016-2021
Table Global Gemcitabine Hydrochloride Production (Unit) 2016-2021
Table Global Gemcitabine Hydrochloride Production Share 2016-2021
Figure North Gemcitabine Hydrochloride Production (Unit) Forecast 2016-2021
Figure EMEA Gemcitabine Hydrochloride Production (Unit) Forecast 2016-2021
Figure Asia-Pacific Gemcitabine Hydrochloride Production (Unit) Forecast 2016-2021
Figure ROW Gemcitabine Hydrochloride Production (Unit) Forecast 2016-2021
Figure Global Gemcitabine Hydrochloride Revenue (M USD) Forecast 2016-2021
Table Global Gemcitabine Hydrochloride Revenue (M USD) 2016-2021
Table Global Gemcitabine Hydrochloride Revenue Share 2016-2021
Figure North America Gemcitabine Hydrochloride Revenue (M USD) Forecast 2016-2021
Figure EMEA Gemcitabine Hydrochloride Revenue (M USD) Forecast 2016-2021
Figure Asia-Pacific Gemcitabine Hydrochloride Revenue (M USD) Forecast 2016-2021
Figure ROW Gemcitabine Hydrochloride Revenue (M USD) Forecast 2016-2021
Figure Global Gemcitabine Hydrochloride Consumption Volume (Unit) 2016-2021
Table Global Gemcitabine Hydrochloride Consumption Volume (Unit) 2016-2021
Table Global Gemcitabine Hydrochloride Consumption Volume Share 2016-2021
Figure North America Gemcitabine Hydrochloride Consumption (Unit) Forecast
Figure EMEA Gemcitabine Hydrochloride Consumption (Unit) Forecast
Figure Asia-Pacific Gemcitabine Hydrochloride Consumption (Unit) Forecast
Figure ROW Gemcitabine Hydrochloride Consumption (Unit) Forecast
Figure Global Gemcitabine Hydrochloride Consumption Volume (Unit) 2021
Table Global Gemcitabine Hydrochloride Consumption Volume (Unit) 2016-2021
Table Global Gemcitabine Hydrochloride Consumption Volume Share 2016-2021
Table Key Strategies for Gemcitabine Hydrochloride Multinational Corporations
Table Key Strategies for Gemcitabine Hydrochloride Emerging-Market Players
List Of Figures
